45 results
DEF 14A
IMCR
Immunocore Holdings plc
12 Apr 24
Definitive proxy
4:20pm
performance goals that relate to our key business objectives. Supports our corporate strategy and business plan by linking executive performance to pay.
Target … , that it believes is appropriate to achieve the goals of our executive compensation program and our corporate objectives. However, a significant portion
424B7
IMCR
Immunocore Holdings plc
5 Apr 24
Prospectus with selling stockholder info
4:34pm
and Israel, global geopolitical tensions, supply chain disruptions, rising interest rates and rising inflation;
our business strategies and goals … and goals;
our plans to collaborate, or statements regarding our current collaborations, and our ability to find future partners and collaborators
PRE 14A
IMCR
Immunocore Holdings plc
2 Apr 24
Preliminary proxy
4:45pm
goals that relate to our key business objectives. Supports our corporate strategy and business plan by linking executive performance to pay.
Target … , that it believes is appropriate to achieve the goals of our executive compensation program and our corporate objectives. However, a significant portion
S-3ASR
IMCR
Immunocore Holdings plc
20 Mar 24
Automatic shelf registration
8:51pm
and goals;
our plans to collaborate, or statements regarding our current collaborations, and our ability to find future partners and collaborators … rates and rising inflation;
our business strategies and goals;
our plans to collaborate, or statements regarding our current collaborations, and our
8-K
EX-99.1
IMCR
Immunocore Holdings plc
28 Feb 24
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update
4:19pm
candidates or those of, or combined with, its collaboration partners; the Company’s goals to develop and commercialize product candidates based on its
8-K
EX-99.2
n34s4 l4yht
28 Feb 24
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update
4:19pm
10-K
EX-10.12
h8mp813a9mvlkgmg pe
28 Feb 24
Annual report
7:33am
10-K
nrjy 7bx9
28 Feb 24
Annual report
7:33am
10-K
EX-10.14
pv7cr00h7vagyp
28 Feb 24
Annual report
7:33am
10-K
EX-10.13
n4y2hvpu
28 Feb 24
Annual report
7:33am
8-K
EX-99.2
pple9jkvi0ymfnxyhn
29 Jan 24
Immunocore Announces Proposed Convertible Senior Notes Offering
5:06pm
8-K
EX-99.1
d7s5y
5 Jan 24
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
7:19am
8-K
EX-99.2
1ohoj2333wppqd4tc
5 Jan 24
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
7:19am
6-K
EX-99.3
zoke3peim8ov4hli
7 Nov 23
Current report (foreign)
7:09am
6-K
EX-99.4
csu733xhc
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
424B7
6wwucw
30 Sep 22
Prospectus with selling stockholder info
4:15pm
424B5
g60h 94yyit5
9 Sep 22
Prospectus supplement for primary offering
4:23pm
6-K
gtk8qgz49k9q4e0y
20 Jul 22
Securities Purchase Agreement
4:06pm
6-K
EX-99.3
n99j75 zfujdlt
20 Jul 22
Securities Purchase Agreement
4:06pm
424B7
vpk8wd83
5 May 22
Prospectus with selling stockholder info
12:00am